These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8279030)

  • 1. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
    Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
    Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic skin grafting for extensive skin chronic graft-versus-host disease.
    Kondo S; Tamura K; Makino S; Takamatsu Y
    Int J Hematol; 1994 Aug; 60(2):151-5. PubMed ID: 7948965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
    Baumeister RG; Riel KA; Kolb HJ
    Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
    Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
    Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ; Strutton GM; Robertson IM; Weedon D
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation.
    Aranha FJ; Vigorito AC; De Sousa CA; Oliveira GB; Zulli R; Lorand-Metze I
    Haematologica; 2002 Feb; 87(2):219-20. PubMed ID: 11836174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
    Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
    Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast media triggering cutaneous graft-versus-host disease.
    Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
    Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
    Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor.
    Ammer J; Prantl L; Holler B; Landfried K; Wolff D; Karrer S; Andreesen R; Holler E
    Bone Marrow Transplant; 2012 Oct; 47(10):1368-9. PubMed ID: 22343673
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
    Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
    Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
    Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
    Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an upper age limit for bone marrow transplantation?
    Popplewell LL; Forman SJ
    Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K
    Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic tolerance to skin allograft after graft-versus-host disease.
    Elias BG; Meunier DI; Squifflet JP; Marot L; Weynand B; VanWijck RR; Bayet B
    Plast Reconstr Surg; 2007 Mar; 119(3):40e-44e. PubMed ID: 17312474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.